Health In Tech Inc. Announces New Restricted Stock Awards for Executive Team Tied to Program Development
Health in Tech Inc., a Nevada-based corporation, has announced new compensation terms for its top executives in connection with the development of two new programs, "Program 1" and "Program 2." The Compensation Committee of the Board of Directors approved restricted stock awards (RSAs) for CEO Tim Johnson, CFO Linlin (Julia) Qian, and CTO (Mo) Imran Yousuf on August 15, 2025. Mr. Johnson will receive 34,000 shares of restricted stock, split equally between the two programs. Ms. Qian will receive a total of 27,000 shares, with 10,000 shares for Program 1 and 17,000 shares for Program 2. Mr. Yousuf is set to receive 7,000 shares, with an equal split between the two programs. The vesting of these shares is contingent upon the successful launch and full operational status of the programs in the marketplace, with a structured vesting schedule for each program. The RSAs were issued under the company's Equity Incentive Plan.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Health in Tech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-078148), on August 19, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.